Ovid Application Error
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Yang, Xiang-Jiao; Ogryzko, Vasily V.; Nishikawa, Jun-ichi; Howard, Bruce H.; Nakatani, Yoshihiro [Article] Nature. 382(6589):319-324, July 25, 1996.
(Format: HTML)
The adenoviral oncoprotein E1A induces progression through the cell cycle by binding to the products of the p300/CBP and retinoblastoma gene families. A new cellular p300/CBP-associated factor (P/CAF) having intrinsic histone acetylase activity has been identified that competes with E1A. Exogenous expression of P/CAF in HeLa cells inhibits cell-cycle progression and counteracts the mitogenic activity of E1A. E1A disturbs the normal cellular interaction between p300/CBP and its associated histone acetylase.
(C) 1996 Macmillan Magazines Ltd.